Medication info

Nuclein Tablets (Clopidogrel Sulfate)

Prescription medicationTabletExpired
Ingredient · strength
Clopidogrel Bisulfate›97.875mg / 1 tablet
Manufacturer / importer
Alpha Pharmaceuticals Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets - 30 tablets/bottle, 100 tablets - 100 tablets/bottle
Approval status
Expired

MFDS item code 201905498 · Approved 2019.08.05

This product's status changed to Expired on 2024.08.05. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of atherosclerosis symptoms; improvement of acute coronary syndrome symptoms; prevention of blood clots in atrial fibrillation
Who uses it
Adults
Adult dosage
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Concomitant administration of aspirin 75 ~ 325 mg once daily is required. 3. For patients with atrial fibrillation, administer this drug 75 mg orally once daily. Concomitant administration of aspirin 75 ~ 100 mg once daily is required. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic impairment and a bleeding diathesis is limited. This drug may be administered without regard to food.

Ingredients

Manufacturer
Alpha Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of atherosclerosis symptoms; improvement of acute coronary syndrome symptoms; prevention of blood clots in atrial fibrillation

  • Ischemic stroke
  • myocardial infarction
  • peripheral artery disease
  • acute coronary syndrome
  • unstable angina
  • non-Q-wave myocardial infarction
  • cardiovascular abnormalities
  • stroke
  • refractory ischemia
  • vascular risk factors
  • bleeding risk
  • atrial fibrillation.
View approved original text

This medication is used to improve symptoms in adult patients related to atherosclerosis, such as ischemic stroke, myocardial infarction, and peripheral artery disease. It also helps alleviate serious symptoms such as death from cardiovascular issues, myocardial infarction, and stroke in patients with acute coronary syndrome. In patients with atrial fibrillation where vitamin K antagonist therapy is difficult due to multiple vascular risk factors, this drug is effective in reducing the risk of stroke and thromboembolism. It plays an important role in preventing complications related to cardiovascular diseases and improving symptoms, thereby assisting patients' health.

Dosage and Administration

Adult dosage

○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), initiate treatment on the first day with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg once daily orally. Concomitant administration of aspirin 75 ~ 325 mg once daily is required. 3. For patients with atrial fibrillation, administer this drug 75 mg orally once daily. Concomitant administration of aspirin 75 ~ 100 mg once daily is required. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate hepatic impairment and a bleeding diathesis is limited. This drug may be administered without regard to food.

Precautions

This drug prevents platelets from sticking together, thereby preventing blood clotting. Before taking this medication, if CYP2C19 genetic enzyme activity is reduced, the drug's effectiveness may be diminished, so consultation with a physician is advised. Moreover, taking this medication alongside drugs that activate the CYP2C19 enzyme may increase the risk of bleeding, so it is recommended not to combine these. Patients with an allergy to this medication, those with bleeding, severe liver damage, breastfeeding women, and those with specific genetic diseases such as lactose intolerance should not take this medication. Patients at high risk of bleeding or scheduled for surgery should be cautious about taking this medication and are advised to discontinue its use 5 to 7 days prior to surgery. Also, caution is necessary when taking it with other medications that increase the risk of bleeding. During treatment with this drug, bleeding may take longer to stop, so if signs of bleeding occur, patients should immediately inform their doctor and undergo an examination. Rarely, serious side effects such as a rapid decrease in the number of certain blood cells may occur, therefore, if fever or signs of infection appear, medical staff should be consulted immediately. This medication may have side effects such as gastrointestinal disturbances, diarrhea, headache, and rash, among which bleeding is one of the most significant side effects. While the effects on the fetus during pregnancy are unclear, treatment should not be postponed in emergencies such as myocardial infarction or stroke. If breastfeeding, it should be carefully considered whether to continue breastfeeding or discontinue the medication since it may be excreted in breast milk. Elderly patients or those with impaired kidney or liver function are at higher risk of bleeding, therefore dose adjustments and careful monitoring are necessary. In case of overdose, bleeding time may be prolonged and the risk of bleeding may increase; while no specific antidote exists, platelet transfusion may reverse the effects. The safety and efficacy of this medication have not been sufficiently established in children, therefore its use is not recommended. When storing this medication, it should be kept out of reach of children, and transferring to other containers should be avoided.

Side effects

  • Hemorrhage
  • gastrointestinal bleeding
  • purpura
  • contusion
  • hematoma
  • epistaxis
  • hematoma
  • hematuria
  • intraocular hemorrhage
  • intracranial hemorrhage
Show 89 more
  • severe neutropenia
  • aplastic anemia
  • thrombocytopenia
  • gastrointestinal symptoms
  • abdominal pain
  • dyspepsia
  • diarrhea
  • nausea
  • rash
  • pruritus
  • chest pain
  • accidental injury
  • influenza-like illness
  • pain
  • fatigue
  • edema
  • hypertension
  • headache
  • dizziness
  • depression
  • upper respiratory tract infection
  • dyspnea
  • rhinitis
  • bronchitis
  • cough
  • urinary tract infection
  • syncope
  • palpitations
  • asthenia
  • fever
  • hernia
  • heart failure
  • atrial fibrillation
  • leg cramps
  • sensory neuropathy
  • neuralgia
  • dysesthesia
  • vertigo
  • constipation
  • vomiting
  • increased liver enzymes
  • gout
  • hyperuricemia
  • non-protein nitrogen increase
  • arthralgia
  • arthritis
  • anxiety
  • insomnia
  • anemia
  • melena
  • cerebral hemorrhage
  • gingival bleeding
  • pneumonia
  • sinusitis
  • eczema
  • skin ulcer
  • cystitis
  • cataract
  • conjunctivitis
  • reduced motor function
  • tremor
  • voice disorder
  • abnormal gait
  • hyperactivity
  • ataxia
  • sensory disturbance
  • insomnia
  • depression
  • forgetfulness
  • anxiety
  • confusion
  • hallucination
  • taste disorder
  • taste loss
  • angioedema
  • vesicular dermatitis
  • drug-induced hypersensitivity syndrome
  • eosinophilia
  • drug rash
  • lichen planus
  • myalgia
  • glomerulopathy
  • gynecomastia
  • fever
  • abnormal liver function tests
  • increased blood creatinine
  • cholecystitis
  • hematemesis
  • spinal hematoma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius to effectively preserve the drug’s efficacy and safety.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets - 30 tablets/bottle, 100 tablets - 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.